Skip to main content
Clinical Trials/NCT03137355
NCT03137355
Recruiting
Not Applicable

The International Registry for Leigh Syndrome

The University of Texas Health Science Center, Houston1 site in 1 country200 target enrollmentJune 17, 2015

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Leigh Syndrome
Sponsor
The University of Texas Health Science Center, Houston
Enrollment
200
Locations
1
Primary Endpoint
Phenotypical characteristics of Leigh syndrome
Status
Recruiting
Last Updated
2 years ago

Overview

Brief Summary

The purpose of this study is to develop a database containing clinical and laboratory information for patients with Leigh syndrome. The goal is to provide a greater understanding of Leigh syndrome allowing further characterization of this disease.

Detailed Description

Leigh syndrome, also known as juvenile sub-acute necrotizing encephalopathy, is a progressive neurodegenerative disorder associated with dysfunction of mitochondrial oxidative phosphorylation (OXPHOS). First described in 1951 by British neuropsychiatrist Archibald Denis Leigh, the condition has evolved from a post mortem diagnosis to a clinical entity with characteristic radiologic and laboratory findings. Leigh syndrome is a rare and heterogeneous disease, finding a substantial number of patients to study is difficult. The lack of natural history data in Leigh syndrome and the small number of patients included in clinical reports thus far has limited the ability to fully comprehend the progression of this disease and assess prognostic factors. A Leigh syndrome database will help improve our understanding of this rare disease leading to an improved ability to predict outcomes and/or improve treatment paradigms. Collecting natural history data on Leigh syndrome and integrating this information into a database will be useful in understanding the course of the disease and identifying trends.

Registry
clinicaltrials.gov
Start Date
June 17, 2015
End Date
June 17, 2030
Last Updated
2 years ago
Study Type
Observational
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Mary Kay Koenig

Professor

The University of Texas Health Science Center, Houston

Eligibility Criteria

Inclusion Criteria

  • All participants with a diagnosis of Leigh syndrome will be invited to participate

Exclusion Criteria

  • People without Leigh syndrome

Outcomes

Primary Outcomes

Phenotypical characteristics of Leigh syndrome

Time Frame: 10 years

The goal of this project is to collect longitudinal data on the natural history of Leigh syndrome.

Study Sites (1)

Loading locations...

Similar Trials